rs137853150
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_006019.4(TCIRG1):c.1213G>A(p.Gly405Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006019.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCIRG1 | NM_006019.4 | c.1213G>A | p.Gly405Arg | missense_variant | 11/20 | ENST00000265686.8 | NP_006010.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCIRG1 | ENST00000265686.8 | c.1213G>A | p.Gly405Arg | missense_variant | 11/20 | 1 | NM_006019.4 | ENSP00000265686.3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152150Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000718 AC: 18AN: 250716Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135748
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461766Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 8AN XY: 727180
GnomAD4 genome AF: 0.000191 AC: 29AN: 152150Hom.: 0 Cov.: 30 AF XY: 0.000323 AC XY: 24AN XY: 74324
ClinVar
Submissions by phenotype
Autosomal recessive osteopetrosis 1 Pathogenic:7
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Lab, Department of Haematology, Christian Medical College | May 20, 2022 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2003 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | May 31, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 21, 2022 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 11, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 14, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Nov 06, 2018 | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM2,PP3,PP5. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 405 of the TCIRG1 protein (p.Gly405Arg). This variant is present in population databases (rs137853150, gnomAD 0.04%). This missense change has been observed in individuals with osteopetrosis (PMID: 11532986, 12552563, 29363653). ClinVar contains an entry for this variant (Variation ID: 5463). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TCIRG1 protein function with a positive predictive value of 80%. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. - |
Osteopetrosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 04, 2022 | Variant summary: TCIRG1 c.1213G>A (p.Gly405Arg) results in a non-conservative amino acid change located in a highly conserved amino acid within a Transmembrane domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.2e-05 in 250716 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in TCIRG1 causing Osteopetrosis (7.2e-05 vs 0.0016), allowing no conclusion about variant significance. c.1213G>A has been reported in the literature in multiple individuals affected with Osteopetrosis (Sobacchi_2001, Cao_2018). These data indicate that the variant is very likely to be associated with disease. One publication reports experimental evidence evaluating an impact on protein function in yeast (Ochotny_2006), finding that the variant results in reduced proton pump and ATPase activity. The variant is detected in trans with other known pathogenic variants (e.g. c.1331G>T, p.R444L), suggesting a pathogenic role. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at